肺浸润性黏液腺癌1例报告及文献复习

doi:10.13481/j.1671-587x.20200333

吉林大学学报(医学版) ›› 2020, Vol. 46 ›› Issue (03): 634-638.doi: 10.13481/j.1671-587x.20200333

• 临床医学 • 上一篇

肺浸润性黏液腺癌1例报告及文献复习

赵敏¹, 金鑫², 邸鑫¹, 田畅¹, 刘伽莹¹, 丛珊¹, 王珂¹

1. 吉林大学第二医院呼吸与危重症医学科, 吉林长春 130041;
2. 吉林大学第二医院肿瘤血液科, 吉林长春 130041

收稿日期:2019-07-11 发布日期:2020-06-11
通讯作者: 王珂,教授,主任医师,博士研究生导师(Tel:0431-81136820,E-mail:kewangm1@hotmail.com) E-mail:kewangm1@hotmail.com
作者简介:赵敏(1994-),女,内蒙古自治区包头市人,在读医学硕士,主要从事肺癌诊治和肺部感染性疾病方面的研究。
基金资助:
吉林省科技厅科研基金资助课题（20180101103JC）；吉林省科技厅科技发展计划项目资助课题（20190303162SF，20191102012YY）

Invasive mucinous adenocarcinoma of lung: A case report and literature review

ZHAO Min¹, JIN Xin², DI Xin¹, TIAN Chang¹, LIU Jiaying¹, CONG Shan¹, WANG Ke¹

1. Department of Respiratory and Critical Care Medicine, Second Hospital, Jilin University, Changchun 130041, China;
2. Department of Oncology and Hematology, Second Hospital, Jilin University, Changchun 130041, China

Received:2019-07-11 Published:2020-06-11

摘要/Abstract

摘要： 目的：探讨肺浸润性黏液腺癌（IMAs）患者的临床特征、诊断方法和治疗过程，提高临床医生对IMAs的认识。方法：收集1例IMAs患者的一般资料、影像学表现和治疗方案，并进行相关文献复习。结果：患者，女性，42岁，因咳嗽和咳痰入院，CT检查显示双肺斑片状影，因疑似双肺肺炎行抗感染治疗后症状未见好转，经支气管镜肺活检术（TBLB）及胸水脱落细胞检测结果均为炎性表现，后经皮穿刺活检病理回报为IMAs。基因检测结果为KRAS外显子2点突变。行紫杉醇加卡铂并联合应用血管靶向药物贝伐珠单抗化疗后，患者临床症状明显改善，肺部影像学表现明显改变。结论：IMAs是一种特殊病理类型的肺腺癌（ADCs），该类患者影像学表现多样，基因表达特殊，治疗原则与其他类型ADCs不同。

关键词: 肺浸润性黏液腺癌, 肺腺癌, 基因突变, 影像学表现

Abstract: Objective: To investigate the clinical characteristics and diagnosis and treatment process of a patient with invasive mucinous adenocarcinoma (IMAs)of lung,and to improve the clinician's understanding of IMAs. Methods: The general materials, imaging manifestations and treatment plan of a patient with IMAs were collected, and the related literature review was conducted. Results: A 42-year-old female patient was admitted to hospital due to cough and expectoration, the CT examination results showed the bilateral lung patchy shadows, the patient was suspected of having pneumonia.After anti-infective treatment, the patient's symptoms did not improve. The pathological findings of transbronchial lung biopsy(TBLB) and the examination of exfoliated cells of pleural fluid all showed inflammation, and the pathological result of percutaneous biopsy was IMAs. The result of gene detection was 2-point mutation in exon of KRAS. After chemotherapy with paclitaxel plus carboplatin combined with bevacizumab, the symptoms of the patients were improved significantly, and the changes of imaging manifestations were obvious. Conclusion: IMAs is a special pathological type of lung adenocarcinomas (ADCs) with various imaging manifestations and specific gene expression. The treatment principles are different from those of the other types of ADCs.

Key words: invasive mucinous adenocarcinoma of lung, lung adenocarcinomas, gene mutation, imaging manifestation

中图分类号:

R563.9

赵敏, 金鑫, 邸鑫, 田畅, 刘伽莹, 丛珊, 王珂. 肺浸润性黏液腺癌1例报告及文献复习[J]. 吉林大学学报(医学版), 2020, 46(03): 634-638.

ZHAO Min, JIN Xin, DI Xin, TIAN Chang, LIU Jiaying, CONG Shan, WANG Ke. Invasive mucinous adenocarcinoma of lung: A case report and literature review[J]. Journal of Jilin University(Medicine Edition), 2020, 46(03): 634-638.

参考文献

[1] BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA-Cancer J Clin,2018, 68(6):394-424.
[2] TRAVIS W D, BRAMBILLA E, NOGUCHI M, et al. International association for the study of lung cancer/American thoracic society/European respiratory society international multidisciplinary classification of lung adenocarcinoma[J]. J Thorac Oncol, 2011,6(2):244-285.
[3] CASALI C, ROSSI G, MARCHIONI A, et al. A single institution-based retrospective study of surgically treated bronchioloalveolar adenocarcinoma of the lung:clinicopathologic analysis, molecular features, and possible pitfalls in routine practice[J]. J Thorac Oncol,2010,5(6):830-836.
[4] CHA M J, LEE K S, KIM T J, et al. Solitary nodular invasive mucinous adenocarcinoma of the lung:imaging diagnosis using the morphologic-metabolic dissociation sign[J]. Korean J Radiol, 2019,20(3):513-521.
[5] 马洪波,周琪,张献全.非小细胞肺癌非EGFR驱动基因与靶向治疗研究进展[J].现代医药卫生,2018,34(20):3180-3183.
[6] OU S H, AHN J S, De PETRIS L, et al. Alectinib in crizotinib-refractory alk-rearranged non-small-cell lung cancer:a phase II global study[J]. J Clin Oncol,2016,34(7):661-668.
[7] MARCHETTI A, BUTTITTA F, PELLEGRINI S, et al. Bronchioloalveolar lung carcinomas:K-ras mutations are constant events in the mucinous subtype[J]. J Pathol,1996, 179(3):254-259.
[8] HIGASHIYAMA M, DOI O, KODAMA K, et al. Cystic mucinous adenocarcinoma of the lung, two cases of cystic variant of mucus-producing lung adenocarcinoma[J]. Chest,1992, 101(3):763-766.
[9] SHIM H S, MARI-KENUDSON, ZHENG Z L, et al. Unique genetic and survival characteristics of invasive mucinous adenocarcinoma of the lung[J]. J Thorac Oncol,2015,10(8):1156-1162.
[10] 王红辉,刘婉洁,张翔辰,等.肺粘液腺癌1例报道[J].影像研究与医学应用,2018,2(15):164-165.
[11] LEE H Y, CHA M J, LEE K S, et al. Prognosis in resected invasive mucinous adenocarcinomas of the lung:related factors and comparison with resected nonmucinous adenocarcinomas[J]. J Thorac Oncol,2016, 11(7):1064-1073.
[12] WATANABE H, SAITO H, YOKOSE T, et al. Relation between thin-section computed tomography and clinical findings of mucinous adenocarcinoma[J]. Ann Thorac Surg,2015,99(3):975-981.
[13] LIN J J, CARDARELLA S, LYDON C A, et al. Five year survival in egfr-mutant metastatic lung adenocarcinoma treated with egfr-tkis[J]. J Thorac Oncol,2016,11(4):556-565.
[14] KADOTA K, YEH Y C, D'ANGELO S P, et al. Associations between mutations and histologic patterns of mucin in lung adenocarcinoma:invasive mucinous pattern and extracellular mucin are associated with kras mutation[J]. Am J Surg Pathol,2014,38(8):1118-1127.
[15] ADDERLEY H, BLACKHALL F H, LINDSAY C R. KRAS-mutant non-small cell lung cancer:Converging small molecules and immune checkpoint inhibition[J]. EBioMedicine,2019,41:711-716.
[16] DONG Z Y, ZHONG W Z, ZHANG X C, et al. Potential predictive value of TP53 and KRAS mutation status for response to PD-1 blockade immunotherapy in lung adenocarcinoma[J]. Clin Cancer Res,2017,23(12):3012-3024.
[17] HELLMANN M D, NATHANSON T, RIZVI H, et al. Genomic features of response to combination immunotherapy in patients with advanced non-small-cell lung cancer[J].Cancer Cell, 2018,33(5):843-852.
[18] 李涛,张娟,胡毅.复合型小细胞肺癌研究进展[J].解放军医学杂志,2018,43(9):799-805.
[19] 支修益,吴一龙,马胜林,等.原发性肺癌诊疗规范(2011年版)[J].中国肺癌杂志,2012,15(12):677-688.

肺浸润性黏液腺癌1例报告及文献复习

Invasive mucinous adenocarcinoma of lung: A case report and literature review

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	苏龙, 张云蔚, 王卓, 宋飞, 秦田雪, 高素君. 紫草素对人白血病MV4-11细胞的增殖抑制和促凋亡作用[J]. 吉林大学学报(医学版), 2020, 46(01): 96-101.
[2]	房惠, 杨红宇, 马绪哲, 陈立松, 盖晓东, 历春. 叉头蛋白3对肺腺癌细胞增殖和化疗药物顺铂敏感性的影响[J]. 吉林大学学报(医学版), 2019, 45(06): 1261-1266.
[3]	胡晓, 於秋燕, 徐文, 王春红, 金立方, 金鑫, 李小丰, 王秀丽, 于晓艳, 李景贺. 骨髓增殖性肿瘤患者JAK2V617F突变与临床特征的关联性分析及其临床意义[J]. 吉林大学学报(医学版), 2019, 45(05): 1106-1112.
[4]	魏佳, 王瑶琪, 孙旭, 逄仁柱, 杨帅, 石亮, 李勇, 孟宪瑛. 甲状腺癌相关基因及其在临床诊断中应用的研究进展[J]. 吉林大学学报(医学版), 2018, 44(04): 880-885.
[5]	杨易, 包康达, 周彦兵, 袁超, 李勇, 刘晓明, 徐金瑞. Wnt5a对人肺腺癌A549细胞凋亡的调控作用及其机制[J]. 吉林大学学报(医学版), 2018, 44(02): 229-234.
[6]	徐烁, 孟宪瑛, 逄仁柱, 杨帅, 韩佳滨, 孙旭, 朱继红. Ki-67和BRAF基因突变与甲状腺乳头状癌侵袭性关系的研究进展[J]. 吉林大学学报(医学版), 2016, 42(06): 1259-1262.
[7]	林雪君，颜康康，赵龙宇，鲍红红，李双，刘晓冬，刘欣. 肺癌患者吸烟与p53基因突变关联性的Meta分析[J]. 吉林大学学报(医学版), 2014, 40(05): 1046-1050.
[8]	曹新梅，张岱权，王栩，夏纪毅，黄黎，高燕. C-erbB-2 shRNA对小鼠肺腺癌细胞化疗敏感性的影响及其机制[J]. 吉林大学学报(医学版), 2014, 40(04): 777-781.
[9]	胡瑞萍,崔久嵬,李薇,张福明,韩薇,杜忠华,韩秀丽,刘晓玲,李红兵,续薇. 初治急性髓系白血病患者CEBPA基因突变检测及其临床意义[J]. 吉林大学学报(医学版), 2014, 40(02): 389-394.
[10]	王槐栋，张晓天，张超，关世慧，董君雪，牟佳，王放，郑敬彤. DNA测序技术在不同药物压力下大肠埃希菌耐药性产生机理研究中的应用[J]. 吉林大学学报(医学版), 2014, 40(01): 109-112.
[11]	张波，朱慧勇 . 骨纤维异常增殖症的发病机制及治疗的研究进展[J]. 吉林大学学报(医学版), 2013, 39(5): 1081-1084.
[12]	杨艳明,方芳，刘念，曲志杰，王志成，张艳秋. pEgr1-hsTRAIL质粒对肺腺癌A549细胞放射敏感性及DR4和DR5表达水平的影响[J]. 吉林大学学报(医学版), 2013, 39(2): 199-203.
[13]	黎萍\|张捷\|李亚荣\|王珂\|苏振中. 靶向Ku70基因siRNA对人肺腺癌细胞顺铂耐药性的逆转作用靶向Ku70基因siRNA对人肺腺癌细胞顺铂耐药性的逆转作用[J]. J4, 2012, 38(2): 240-245.
[14]	赵彤, 王秀兰, 刘勇, 王若雨. 表皮生长因子受体单克隆抗体对辐射诱导肺腺癌细胞SPC-A-1的增敏作用[J]. J4, 2011, 37(3): 483-486.
[15]	刘莉, 张志民, 王丽颖, 郑鹏, 李会. 变形链球菌耐氟菌株中耐酸相关基因gluA 突变的检测及其意义[J]. J4, 2011, 37(1): 80-83.